At BIO 2026, Thermo Fisher's Anil Kane explains how AI is reshaping CDMO workflows and what biotechs should prioritize when choosing a development partner.
Nicholas Jacobus
Advertisement
Articles by Nicholas Jacobus
Trump to fire FDA Commissioner Marty Makary amid controversy over vaccine and drug policy decisions, leaving the agency without confirmed leadership.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Thermo Fisher's Kane Says AI Is Reshaping How CDMOs Add Value
2
Don’t Make AI Smarter. Make It Traceable.
3
FDA Approves Pfizer’s Breast Cancer Treatment
4
MilliporeSigma's Arana Maps the Gaps Holding Back CGT Manufacturing
5